Development of hemostasis in the fetus

Thrombosis Research

Volumn 115, Issue SUPPL., 2005, Pages 55-63

  Manco Johnson, M J ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BLOOD CLOTTING FACTOR; CARBAMAZEPINE; FIBRINOGEN; PHENOBARBITAL; PHENYTOIN; PHYTOMENADIONE; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; VALPROIC ACID; VITAMIN K DEPENDENT CARBOXYLASE; VITAMIN K GROUP; VON WILLEBRAND FACTOR; WARFARIN;

BLOOD CLOTTING; CARBOXYLATION; CONFERENCE PAPER; FETAL HEMORRHAGE; FETUS; HEMOSTASIS; HUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; THROMBOCYTE; VITAMIN K DEFICIENCY;

BLOOD COAGULATION FACTORS; FEMALE; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEMOSTASIS; HUMANS; PREGNANCY;

EID: 12544260392     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (71)

1. Hathaway WE, Bonnar J. Hemostatic Disorders of the Pregnant Woman and Newborn Infant. New York, NY: Elsevier Science Publishing Company; 1987. p. 57-75.
2. Andrew M, Paes B, Johnston M. Development of the haemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol 1990;12:95-104.
3. Aronis S, et al: Indications of coagulation and/or fibrinolytic systemactivation in healthy and sick very-low-birth-weight neonates. Biol Neonate 1998;74:337.
4. Barnard DR, Simmons MA, Hathaway WE. Coagulation studies in extremely premature infants. Pediatr Res 1979;13:1330-5.
5. Andrew M, Paes B, Johnston M, Mitchell L, Tollefsen DM, Castle V, Powers P. Development of the human coagulation system in the healthy premature infant. Blood 1988;72:1651-7.
6. Smith AA, Jacobson LJ, Miller BI, et al. A new euglobulin clot lysis assay for global fibrinolysis. Thromb Res 2003;112:329-37.
7. Goldenberg N, Hathaway WE, Jacobson L, Manco-Johnson MJ. Evaluation of physiologic and pathologic alterations of coagulation and fibrinolysis using a new global assay. Blood 2004 [abst, in press].
8. Travis PA, Bovill EG, Hamill B, Tindle B. Detection of factor VIII von Willebrand Factor in endothelial cells in first-trimester fetuses. Arch Pathol Lab Med 1988;112:40-2.
9. Tuddenham EGD, Shearn SAM, Peake IR, Giddings JC, Blood AL. Tissue localization and synthesis of factor-VIII-related antigen in the human foetus. Brit J Haematol 1974;26:669-77.
10. Kawamoto S, MatsumotoY, Miuno K, Okubo K, Matsubara K. Expression profiles of active genes in human and mouse livers. Gene 1996;174:151-8.
11. Hassan HJ, Leonardi A, Chelucci C, Matiia G, Macioce G, Buerriero R, et al. Blood coagulation factors in human embryonic-fetal development: preferential expression of the FVII/tissue factor pathway. Blood 1990;76:1158-64.
12. Malhotra K, Luehrsen KR, Costello LL, Raich TJ, Sim K, Foltz L, et al. Identification of differentially expressed mRNAs in human liver across gestation. Nucleic Acids Research 1999;27:839-47.
13. Luther T, Flossel C, Mackman N, Bierhaus A, Kasper M, Albrecht S, et al. Tissue factor expression during human and mouse development. Am J Pathol 1996;149:101-13.
14. Bugge TH, Xiao Q, Konbrinck KW, Flick MJ, Holmback K, Danton M, et al. Fatal embryonic bleeding events in mice lacking tissue factor the cell-associated initiator of blood coagulation. Proc Natl Acad Sci USA 1996;93:6258-63.
15. Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze Jr GJ. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 1996;88:1583-7.
16. Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, Van Vlaenderen I, Demunck H, Kasper M, Breier G, Evrard P, Muller M, Risau W, Edgington T, Collen D. Role of tissue factor in embryonic blood vessel development. Nature 1996;383:73-5.
17. Xue J,Wu Q,Westfield LA, Tuley EA, Lu D, Zhang Q, Shim K, Zheng X, Sadler JE. Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice. Proc Natl Acad Sci USA 1998;95:7603-7.
18. Cui J, O'Shea KS, Purkayastha A, Saunders TL, Ginsburg D. Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature 1996;384:66-8.
19. Edstrom CS, Calhoun DA, Christensen RD. Expression of tissue factor pathway inhibitor in human fetal and placental tissues. Early Hum Dev 2000;59:77-84.
20. Huang ZF, Higuchi D, Lasky N, Broze Jr GJ. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood 1997;90:944-51.
21. Lorant DE, Li W, Tabatabaei N, Garver MK, Albertine KH. P-selectin expression by endothelial cells is decreased in neonatal rats and human premature infants. Blood 1999;94:600-9.
22. Hackel C, Radig K, Rose I, Roessner A. The urokinase plasminogen activator (u-PA) and its inhibitor (PAI-1) in embryo-fetal bone formation in the human: an immunohistochemical study. Anat Embryol (Berl) 1995;192:363-8.
23. Reverdiau-Moalic P, Gruel Y, Delahousse B, Rupin A, Huart MC, Body G, Leroy J. Comparative study of the fibrinolytic system in human fetuses and in pregnant women. Thromb Res 1991;61:489-99.
24. Reverdiau-MoalicP, Delahousse B, Body G, Bardos P, Leroy J, Gruel Y. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996;88:900-6.
25. Bleyer WA, Hakami N, Shepard TH. The development of hemostasis in the human fetus and newborn infant. J Pediatr 1971;79:838-53.
26. Ekelund H, Hedner U, Astedt B. Fibrinolysis in human foetuses. Acta Paediatr Scan 1970;59:369.
27. Heikinheimo R. Coagulation studies with fetal blood. Biol Neonate 1964;7:319.
28. Holmberg L, Henriksson P, Ekelund H, Åstedt B. Coagulation in the human fetus. J Pediatr 1974;85:860-4.
29. Rivers RP, Hathaway WE. Studies on tissue factor activity and production by leukocytes of human umbilical cord and adult origin. Pediatr Res 1975;9:167-71.
30. Grabowski EF, Carter CA, Tsukurov O, Conroy N, Hsu CY, Abbott W, et al. Comparison of human umbilical vein and adult saphenous vein endothelial cells: implications for newborn hemostasis and for models of endothelial cell function. J Pediatr Hematol Oncol 2000;22:266-8.
31. Streif W, Paes B, Berry L, Andrew M, Andreasen RB, Chan AK. Influence of exogenous factor VIIa on thrombin generation in plasma of fullterm and pre-term newborns. Blood Coagul Fibrinolysis 2000;11:349-57.
32. Menashi S, Aurousseau MH, Gozin D, Daffos F, D'angelo A, Forestier F, Boffa MC. High levels of circulating thrombomodulin in human foetuses and children. Thromb Haemost 1999;81:906-9.
33. Orbe I, Paramo JA, Pinacho A, Hermida J, Rocha E. Plasma thrombomodulin is increased in cord blood of healthy newborns. Thromb Haemost 1995;73:326.
34. Burnstein M, Lewis S, Walter P. Sur l'existence du fibriogène foetal. Sang 1954;25:102.
35. Witt I, Müller H. Phosphorus and hexose content of human foetal fibrinogen. Biochim Biophys Acta 1970:221:402-4.
36. Müller M, Burchard W. Fibrinogen-fibrin transformation. Part III. Particularities for foetal fibrinogen. Thromb Res 1981;24:339-46.
37. Hasegawa N, Sasaki S. A deficiency in A alpha chain's N-terminal alanine residue as a major cause of the slow coagulation of fetal fibrinogen. Thromb Res 1989;54:595-602.
38. Francis JL, Armstrong DJ. Sialic acid and enzymatic desialation of cord blood fibrinogen. Haemostasis 1982;11:223-8.
39. Galanakis DK, Martinez J, McDevitt C, Miller F. Human fetal fibinogen: its characteristics of delayed fibrin formation, high sialic acid and AP peptide content are more marked in preterm than in term samples. Ann NY Acad Sci 1983;408:640-3.
40. Benavent A, Estelles A, Aznar J, Martinez-Sales V, Gilabert J, Fornas E. Dysfunctional plasminogen in full term newborn-study of active site of plasmin. Thromb Haemost 1984;51:67-70.
41. Ries M. Molecular and functional properties of fetal plasminogen and its possible influence on clot lysis in the neonatal period. Semin Thromb Hemost 1997;23:247-52.
42. Ries M, Klinge J, Rauch R, Trusen B, Zenker M, Keuper H, Harms D. In vitro fibrinolysis after adding low doses of plasminogen activator and plasmin generation with and without oxidative inactivation of plasmin inhibitors in newborns and adults. J Pediatr Hematol Oncol 1996;18:346-51.
43. Ries M, Zenker M, Gaffney PJ. Differences between neonates and adults in the urokinase-plasminogen activator (u-PA) pathway of the fibrinolytic system. Thromb Res 2000;100:341-51.
44. Katz JA, Moake JL, McPherson PD, Weinstein MJ, Moise KJ, Carpenter RJ, Sala DJ. Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma. Blood 1989;73:1851-8.
45. Shenkman B, Linder N, Savion N, Tamarin I, Dardik R, Kennet G, German B, Varon D. Increased neonatal platelet deposition on subendothelium under flow conditions: the role of plasma von Willebrand factor. Pediatr Res 1999;45:270-5.
46. Shearer MJ, Rahim S, Barkhan P, Stimmler L. Plasma vitamin K1 in mothers and their newborn babies. Lancet 1982;2(8296):460-3.
47. Mandelbrot L, Guillaumont M, Leclercq M, Lefrere JJ, Gozin D, Daffos F, Forestier F. Placental transfer of vitamin K1 and its implications in fetal hemostasis. Thromb Haemost 1988;60:39-43.
48. Shapiro AD, Jacobson LJ, Armon ME, Manco-Johnson MJ, Hulac P, Lane P, Hathaway WE. Vitamin K deficiency in the newborn infant: prevalence and perinatal risk factors. J Pediatr 1986;109675-80.
49. Bovill EG, Soll RF, Lynch M, Bhushan F, Landesman M, Freije M, Church W, McAuliffe T, Davidson K, Sadowski J. Vitamin K1 metabolism and the production of descarboxy prothrombin and protein C in the term and premature neonate. Blood 1993;81:77-83.
50. Israels LG, Friesen E, Jansen AH, Israels ED. Vitamin K1 increases sister chromatid exchange in vitro in human leukocytes and in vivo in fetal sheep cells: a possible role for "vitamin K deficiency" in the fetus. Pediatr Res 1987;22:405-8.
51. Israels LG, Israels ED. Observations on vitamin K deficiency in the fetus and newborn: has nature made a mistake? Semin Thromb Hemost 1995;21:357-63.
52. Webster WS, Vaghef H, Ryan B, Dencker L, Hellman B. Measurement of DNA damage by the comet assay in rat embryos grown in media containing high concentrations of vitamin K(1). Toxicol In Vitro 2000;14:95-9.
53. Cornelissen M, Steegers-Theunissen R, Kollee L, Eskes T, Vogels-Mentink G, Motohara K, De Abreu R, Monnens L. Increased incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy. Am J Obstet Gynecol 1993;168:923-8.
54. Cornelissen M, Steegers-Theunissen R, Kollee L, Eskes T, Motohara K, Monnens L. Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency. Am J Obstet Gynecol 1993;168:884-8.
55. Berkner KL, Pudota BN. Vitamin K-dependent carboxylation of the carboxylase. Proc Natl Acad Sci U S A 1998;95:466-71.
56. Varnum BC, Young C, Elliot G, Garcia A, Bartley TD, Fridell YW, et al. Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature 1995;373:623-6.
57. Ohashi K, Nagata K, Toshima J, Nakano T, Arita H, Tsuda H, Suzuki K, Mizuno K. Stimulation of sky receptor tyrosine kinase by the product of growth arrest-specific gene 6. J Biol Chem 1995;270:22681-4.
58. Price PA, Poser JW, Raman N. Primary structure of the gamma-carboxyglutamic acid-containing protein from bovine bone. Proc Natl Acad Sci U S A 1976;73:3374-5.
59. Kulman JD, Harris JE, Xie L, Davie EW. Identification of two novel transmembrane g-carboxyglutamic acid proteins expressed broadly in fetal and adult tissues. PNAS 2001;98:1370-5.
60. Jilma-Stahlawetz P, Homoncik M, Jilma B, Folman CC, von dem Borne AD, Beraschek G, Deutinger J, Ulm B, Wppel W, Panzer S. High levels of reticulated platelets and thrombopoietin characterize fetal thrombopoiesis. Br J Haematol 2001;112:466-8.
61. Murray NA, Watts TL, Roberts IA. Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies. Pediatr Res 1998:148-51.
62. Feusner JH. Normal and abnormal bleeding times in neonates and young children utilizing a fully standardized template technic. Am J Clin Pathol 1980 Jul;74(1):73-7.
63. Israels SJ, Cheang T, McMillan-Ward EM, Cheang M. Evaluation of primary hemostasis in neonates with a new in vitro platelet function analyzer. J Pediatri 2000;138:116-9.
64. Meher-Homji NJ, Montemagno R, Thilaganathan B, Nicolaides KH. Platelet size and glycoprotein Ib and IIIa expression in normal fetal and maternal blood. Am J Obstet Gynecol 1994;171:791-6.
65. Jones CR, McCabe R, Hamilton CA, Reid JL. Maternal and fetal platelet responses and adrenoreceptor binding characteristics. Thromb Haemost 1985;53:95-8.
66. Gruel Y, Boizard B, Daffos F, Forestier F, Caen J, Wautier JL. Determination of platelet antigens and glycoproteins in the human fetus. Blood 1986;68:488-92.
67. Mull MM, Hathaway WE. Altered platelet function in newborns. Pediatr Res 1970;4:229-37.
68. Nicolini U, Guarneri D, Gianotti GA, Campagnoli C, Crosignani PG, Gatti L. Maternal and fetal platelet activation in normal pregnancy. Obstet Gynecol 1994;83:65-9.
69. Gelman B, Setty BN, Chen D, Amin-Hanjani S, Stuart MJ. Impaired mobilization of intracellular calcium in neonatal platelets. Pediatr Res 1996 Apr:692-6.
70. Israels SJ, Cheang T, Roberston C, McMillan-Ward EM, McNicol A. Impaired signal transduction in neonatal platelets. Pediatr Res 1999;45:687-91.
71. Bussel JB. Alloimmune thrombocytopenia in the fetus and newborn. Semin Thromb Hemost 2001 Jun;27(3):245-52.